Synergistic Interactions between Repeats in Tau Protein and Aβ Amyloids May Be Responsible for Accelerated Aggregation via Polymorphic States

Amyloid plaques and neurofibrillary tangles simultaneously accumulate in Alzheimer’s disease (AD). It is known that Aβ and tau exist together in the mitochondria; however, the interactions between Aβ oligomers and tau are controversial. Moreover, it is still unclear which specific domains in the tau protein can interact with Aβ oligomers and what could be the effect of these interactions. Herein, we examine three different Aβ–tau oligomeric complexes. These complexes present interactions of Aβ with three domains in the tau protein; all contain high β-structure propensity in their R2, R3, and R4 repeats. Our results show that, among these, Aβ oligomers are likely to interact with the R2 domain to form a stable complex with better alignment in the turn region and the β-structure domain. We therefore propose that the R2 domain can interact with soluble Aβ oligomers and consequently promote aggregation. EM and AFM images and dimensions revealed highly polymorphic tau aggregates. We suggest that the polymorphic tau and Aβ–tau aggregates may be largely due to repeat sequences which are prone to variable turn locations along the tau repeats.

[1]  J. Kuret,et al.  In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. , 2000, Biochemistry.

[2]  J. Ávila,et al.  Polymerization of tau peptides into fibrillar structures. The effect of FTDP‐17 mutations , 1999, FEBS letters.

[3]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[4]  Laxmikant V. Kale,et al.  NAMD2: Greater Scalability for Parallel Molecular Dynamics , 1999 .

[5]  W. Markesbery,et al.  Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.

[6]  I. Mook‐Jung,et al.  Amyloid peptide attenuates the proteasome activity in neuronal cells , 2005, Mechanisms of Ageing and Development.

[7]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[8]  B. Yankner,et al.  β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.

[9]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[10]  Ruth Nussinov,et al.  Hollow core of Alzheimer’s Aβ42 amyloid observed by cryoEM is relevant at physiological pH , 2010, Proceedings of the National Academy of Sciences.

[11]  R. Crowther,et al.  Effects of frontotemporal dementia FTDP‐17 mutations on heparin‐induced assembly of tau filaments , 1999, FEBS letters.

[12]  Da-Wei Li,et al.  Formation and Growth of Oligomers: A Monte Carlo Study of an Amyloid Tau Fragment , 2008, PLoS Comput. Biol..

[13]  Ruth Nussinov,et al.  The unique Alzheimer's β-amyloid triangular fibril has a cavity along the fibril axis under physiological conditions. , 2011, Journal of the American Chemical Society.

[14]  V. Muñoz,et al.  Alpha-helix structure in Alzheimer's disease aggregates of tau-protein. , 2002, Biochemistry.

[15]  Christian Griesinger,et al.  Structural Polymorphism of 441-Residue Tau at Single Residue Resolution , 2009, PLoS biology.

[16]  Daniel J. Muller,et al.  Human Tau Isoforms Assemble into Ribbon-like Fibrils That Display Polymorphic Structure and Stability* , 2010, The Journal of Biological Chemistry.

[17]  M. Hutton,et al.  Missense tau mutations identified in FTDP-17 have a small effect on tau–microtubule interactions , 2000, Brain Research.

[18]  D. Selkoe,et al.  Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. , 2003, Annual review of pharmacology and toxicology.

[19]  Li-Huei Tsai,et al.  Aberrant Cdk5 Activation by p25 Triggers Pathological Events Leading to Neurodegeneration and Neurofibrillary Tangles , 2003, Neuron.

[20]  Jürgen Götz,et al.  Dissecting Toxicity of Tau and β-Amyloid , 2010, Neurodegenerative Diseases.

[21]  Federico Gago,et al.  Phosphorylation modulates the alpha-helical structure and polymerization of a peptide from the third tau microtubule-binding repeat. , 2005, Biochimica et biophysica acta.

[22]  D. Kirschner,et al.  The Formation of Straight and Twisted Filaments from Short Tau Peptides* , 2004, Journal of Biological Chemistry.

[23]  R. Kayed,et al.  Preparation and characterization of neurotoxic tau oligomers. , 2010, Biochemistry.

[24]  K. Tomoo,et al.  Amphipathic helical behavior of the third repeat fragment in the tau microtubule-binding domain, studied by (1)H NMR spectroscopy. , 2002, Biochemical and biophysical research communications.

[25]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[26]  E. Mandelkow,et al.  Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local β-Structure* , 2001, The Journal of Biological Chemistry.

[27]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[28]  C. Brooks,et al.  Novel generalized Born methods , 2002 .

[29]  G. Schellenberg,et al.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Ruth Nussinov,et al.  Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic states , 2010, Proceedings of the National Academy of Sciences.

[31]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[32]  E. Mandelkow,et al.  Tau in Alzheimer's disease. , 1998, Trends in cell biology.

[33]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[34]  R. Langen,et al.  Side Chain-dependent Stacking Modulates Tau Filament Structure* , 2006, Journal of Biological Chemistry.

[35]  F. LaFerla,et al.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.

[36]  F. LaFerla,et al.  Pathways by which Abeta facilitates tau pathology. , 2006, Current Alzheimer research.

[37]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[38]  Martin von Bergen,et al.  Tau aggregation is driven by a transition from random coil to beta sheet structure. , 2005, Biochimica et biophysica acta.

[39]  Charles L. Brooks,et al.  New analytic approximation to the standard molecular volume definition and its application to generalized Born calculations , 2003, J. Comput. Chem..

[40]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[41]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[42]  S. Radford,et al.  Stacked Sets of Parallel, In-register β-Strands of β2-Microglobulin in Amyloid Fibrils Revealed by Site-directed Spin Labeling and Chemical Labeling* , 2010, The Journal of Biological Chemistry.

[43]  J. Trojanowski,et al.  Characterization of tau fibrillization in vitro , 2010, Alzheimer's & Dementia.

[44]  Ruth Nussinov,et al.  Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy. , 2011, Journal of the American Chemical Society.

[45]  R. Nussinov,et al.  Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformation. , 2009, Biophysical journal.

[46]  Christian Griesinger,et al.  Sites of Tau Important for Aggregation Populate β-Structure and Bind to Microtubules and Polyanions* , 2005, Journal of Biological Chemistry.

[47]  F. LaFerla Pathways linking Abeta and tau pathologies. , 2010, Biochemical Society transactions.

[48]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[49]  R. Maccioni,et al.  Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal death , 1999, FEBS letters.

[50]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[51]  Gerd Krause,et al.  General structural motifs of amyloid protofilaments , 2006, Proceedings of the National Academy of Sciences.

[52]  Xiaomin Song,et al.  Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice , 2009, Proceedings of the National Academy of Sciences.

[53]  Michel Goedert,et al.  Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Tetsuaki Arai,et al.  Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Hyonchol Kim,et al.  Granular tau oligomers as intermediates of tau filaments. , 2007, Biochemistry.

[56]  K. Imahori,et al.  Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Tomoo,et al.  Different associational and conformational behaviors between the second and third repeat fragments in the tau microtubule-binding domain. , 2004, European journal of biochemistry.

[58]  J. Götz,et al.  Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice , 2008, Neurodegenerative Diseases.

[59]  J. Ávila,et al.  Tau aggregation followed by atomic force microscopy and surface plasmon resonance, and single molecule tau-tau interaction probed by atomic force spectroscopy. , 2009, Journal of Alzheimer's disease : JAD.

[60]  Michael W. Mahoney,et al.  A five-site model for liquid water and the reproduction of the density anomaly by rigid, nonpolarizable potential functions , 2000 .

[61]  A. Erisir,et al.  Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid , 2006, The Journal of cell biology.

[62]  R. Riek,et al.  3D structure of Alzheimer's amyloid-beta(1-42) fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Ralf Langen,et al.  Template-assisted filament growth by parallel stacking of tau. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Fabrizio Chiti,et al.  A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.

[65]  B. Brooks,et al.  Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .

[66]  F. Dahlquist,et al.  A soluble oligomer of tau associated with fiber formation analyzed by NMR. , 2008, Biochemistry.

[67]  A. Caccamo,et al.  Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation , 2010, Molecular Neurodegeneration.

[68]  D. Eliezer,et al.  Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation. , 2005, Biochemistry.

[69]  David Eisenberg,et al.  Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.

[70]  J. Hardy,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[71]  M. Hutton,et al.  Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations , 1999, FEBS letters.

[72]  Christian Griesinger,et al.  The “Jaws” of the Tau-Microtubule Interaction* , 2007, Journal of Biological Chemistry.

[73]  E. Mandelkow,et al.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.

[74]  M. Klein,et al.  Constant pressure molecular dynamics algorithms , 1994 .

[75]  W. Müller,et al.  Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease , 2006, Experimental Gerontology.

[76]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[77]  C. L. Teoh,et al.  Visualization of polymorphism in apolipoprotein C-II amyloid fibrils. , 2011, Journal of biochemistry.

[78]  I. Grundke‐Iqbal,et al.  Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains , 1994, FEBS letters.

[79]  E. Mandelkow,et al.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[80]  R. Nussinov,et al.  Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape , 2010, Chemical reviews.